Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
Sepragen develops chromatography and bioreactor systems for large-scale pharmaceutical and biopharmaceutical manufacturing, including vaccine production, monoclonal antibodies, and viral vectors. The company serves pharmaceutical manufacturers and contract manufacturers requiring purification and bioprocessing equipment at production scale.
0 investors
0 investors
0 investors
Sequella is a clinical-stage pharmaceutical company developing antibiotics to treat drug-resistant bacterial, fungal, and parasitic infections, including tuberculosis, MDR-TB, XDR-TB, H. pylori, and C. difficile. Its pipeline includes drug candidates such as SQ109 and sutezolid, which have completed phase 2 clinical trials.
0 investors
Sequoia Sciences is a biotechnology company developing vaccines, including a vaccine to prevent recurrent urinary tract infections, with programs spanning clinical development, regulatory strategy, and manufacturing. The company works on immune therapies for infectious diseases and cancer.
0 investors
Sequome uses AI to engineer biological sequences for developing therapeutics, based on its sequence-to-function model called Gene Genie. The company has collaborated with large pharmaceutical firms and Google DeepMind in the drug discovery and biotechnology space.
0 investors
seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients. The company's proprietary plexWell platform enables researchers to streamline NGS workflows.
0 investors
Seranova is a biotech company that combines REAP autoantibody profiling with clinically linked patient cohorts to identify naturally occurring protective autoantibodies against specific extracellular targets and translate those protective associations into therapeutic hypotheses. Its approach treats protective autoantibodies as long-duration human perturbations linked to clinical outcomes for drug discovery.
0 investors
0 investors
0 investors
0 investors
Sermonix Pharmaceuticals is a privately held biotechnology company developing female-specific oncology products, with a lead investigational drug, lasofoxifene, being studied for breast and ovarian cancer. Its ELAINE study evaluates lasofoxifene versus fulvestrant in women with ER+/HER2- metastatic breast cancer carrying an ESR1 mutation.
0 investors
0 investors
Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
0 investors
Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions. The company's lead candidate, aleniglipron, is a GLP-1 receptor agonist in clinical development, supported by a platform combining structure-based drug discovery and computational chemistry.
0 investors